Brain scans reveal hidden damage years after pregnancy complication
NCT ID NCT03600636
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study uses special MRI scans to see if the white matter in the brain gets worse over time in women who have obstetric antiphospholipid syndrome, a condition that can cause pregnancy loss. Researchers will compare brain images from 40 women who were part of an earlier study. The goal is to understand if this condition leads to long-term brain changes, which could help guide future care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If this study finds that white matter deteriorates, it could point toward the need for brain monitoring or early treatment in these patients.
What could go wrong
This is a small, observational study with no treatment being tested. It only looks at brain changes, so it cannot prove any therapy works or is safe.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTIPHOSPHOLIPID SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Nimes
Nîmes, 30029, France